Jason K. Garland serves as the Chief Financial Officer (CFO) at Repligen Corporation, a global life sciences company focused on bioprocessing technologies. In his role, Garland oversees the company's financial strategy, planning, and operations, playing a crucial role in guiding Repligen's growth and financial health. His expertise in finance and strategic planning has been instrumental in driving the company's success in the competitive bioprocessing market. Before joining Repligen, Garland held several high-level financial positions at various organizations. He has a robust background in financial management, having worked in both the life sciences and technology sectors. His previous roles have equipped him with a deep understanding of the financial intricacies involved in scaling businesses and managing complex financial portfolios. Garland's strategic vision and leadership have been key factors in his ability to navigate the challenges of the biopharmaceutical industry and contribute to Repligen's robust financial performance. Garland's achievements at Repligen include leading the company through several successful acquisitions and financings, which have bolstered the company's market position and expanded its product offerings. Under his guidance, Repligen has seen significant revenue growth and improved profitability, reflecting his adeptness at financial stewardship. His commitment to fostering a culture of innovation and excellence within the finance team has also been pivotal in maintaining Repligen's status as a leader in the bioprocessing industry.